Andrés Manuel López Obrador is Mexico’s resident rabble rouser, the populist former mayor of Mexico City who has narrowly lost — and vehemently contested — two presidential bids. He is sure to run again next year, and his MORENA party’s strong showing in Mexico State’s recent gubernatorial election suggest that his chances of winning are good.
But López Obrador’s firebrand style and radical policy proposals have long made markets (and many Mexicans), jittery, writes Salvador Vázquez del Mercado, especially in the age of Donald Trump. Could a more carefully calibrated López Obrador become Mexico’s first left-wing president?
|
Andres Manuel Lopez Obrador (AMLO), right, with Delfina Gomez of his MORENA party. Gómez narrowly lost the Mexico State governor’s race on June 4 but gave her party a boost for the presidency.
Carlos Jasso/REUTERS
Salvador Vázquez del Mercado, Universidad Nacional Autónoma de México (UNAM)
Can Andrés Manuel López Obrador, Mexican politics' long-time left-wing rabble rouser, finally win the presidency?
|
Politics + Society
|
-
Stephanie Kovalchik, Victoria University
The unpredictability of women's tennis in 2017 should make us strongly question the performance of the official rankings – and not simply the players’ performance.
|
|
Environment + Energy
|
-
Nandan Sharalaya, WHU – Otto Beisheim School of Management
Weeks after Trump's withdrawal from the Paris agreement, powerful US cities are asserting themselves like nation-states to maintain the pact made with the world to help save the planet.
-
Katelyn Faulkner, University of Pretoria; Brett Hurley, University of Pretoria; Mark Robertson, University of Pretoria
Many alien plants and animals have been introduced to Africa from other regions and spread from country to country, often having devastating effects.
|
|
Science + Technology
|
-
Gaëll Mainguy, Centre de Recherches Interdisciplinaires (CRI) – USPC
Professor Samir Brahmachari's innovative Open Source Drug Development allows thousands of researchers to work together to discover novel therapies for under-studied diseases.
|
|